These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 2393037)

  • 1. Nephrolithiasis and bone involvement in primary hyperparathyroidism.
    Silverberg SJ; Shane E; Jacobs TP; Siris ES; Gartenberg F; Seldin D; Clemens TL; Bilezikian JP
    Am J Med; 1990 Sep; 89(3):327-34. PubMed ID: 2393037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and evaluation of asymptomatic primary hyperparathyroidism.
    Bilezikian JP; Silverberg SJ; Shane E; Parisien M; Dempster DW
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S85-9; discussion S121-4. PubMed ID: 1662460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dietary calcium intake in primary hyperparathyroidism.
    Locker FG; Silverberg SJ; Bilezikian JP
    Am J Med; 1997 Jun; 102(6):543-50. PubMed ID: 9217669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.
    Thakker RV; Fraher LJ; Adami S; Karmali R; O'Riordan JL
    Bone Miner; 1986 Apr; 1(2):137-44. PubMed ID: 3508721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of diagnostic methods of primary hyperparathyroidism in patients with urolithiasis].
    Ismailov SI; Uzbekov KK; Gaĭbullaev AA; Alimzhanov NA; Nasirov AA; Babakhanov BKh
    Urologiia; 2002; (6):8-11. PubMed ID: 12577570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.
    Pak CY; Nicar MJ; Peterson R; Zerwekh JE; Snyder W
    J Clin Endocrinol Metab; 1981 Sep; 53(3):536-42. PubMed ID: 7263839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers.
    D'Amour P; Gascon-Barré M; Dufresne L; Perreault JP
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):549-62. PubMed ID: 6094046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis.
    Baggio B; Budakovic A; Nassuato MA; Vezzoli G; Manzato E; Luisetto G; Zaninotto M
    Kidney Int; 2000 Sep; 58(3):1278-84. PubMed ID: 10972691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D status in primary hyperparathyroidism in India.
    Harinarayan CV; Gupta N; Kochupillai N
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):351-8. PubMed ID: 7586606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.
    Spivacow FR; Negri AL; del Valle EE; Fradinger E; Martinez C; Polonsky A
    Int Urol Nephrol; 2012 Jun; 44(3):857-63. PubMed ID: 21505756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone mineral density in primary hyperparathyroidism].
    Kosowicz J; Baszko-Błaszyk D; Horst-Sikorska W; Baumann-Antczak A
    Pol Arch Med Wewn; 1999 Feb; 101(2):131-8. PubMed ID: 10723227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of calcium metabolism in patients with hypercalciuria].
    Bichler KH; Strohmaier WL; Mittermüller B
    Urologe A; 1996 Sep; 35(5):408-12. PubMed ID: 8999631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of 128 subjects operated for primary hyperparathyroidism.
    Haddock L; Aguiló F; Vázquez Quintana E; Vázquez MC; Rabell V; Allende M
    P R Health Sci J; 1998 Dec; 17(4):309-16. PubMed ID: 10028537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated to kidney stones in primary hyperparathyroidism.
    Corbetta S; Baccarelli A; Aroldi A; Vicentini L; Fogazzi GB; Eller-Vainicher C; Ponticelli C; Beck-Peccoz P; Spada A
    J Endocrinol Invest; 2005 Feb; 28(2):122-8. PubMed ID: 15887857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.